Degenerative Lumbar Disc Disease Clinical Trial
Official title:
Evaluation of Transcutaneous Stimulation of Lumbosacral Nerve Roots: A Pilot Study
NCT number | NCT02192112 |
Other study ID # | NUVA.NV1301 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 2014 |
Est. completion date | May 8, 2018 |
Verified date | August 2018 |
Source | NuVasive |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Though the utility of NVM5 neuromonitoring by stimulating within the surgical site during
XLIF has been demonstrated, it is hypothesized that more information may be gathered if a
greater section of the motor neural pathway was monitored (i.e., stimulation above the
surgical site and recording the subsequent muscle response in the lower limbs). Currently,
there has not been demonstrated a practical method of stimulating the lumbosacral nerve roots
locally, but well-above the surgical site in this fashion.
This protocol is intended to evaluate the feasibility and reproducibility of using surface
stimulation and return (anode) electrodes to stimulate the lumbosacral nerve roots, and
record responses from the relevant innervated muscle groups of the lower limbs.
Status | Completed |
Enrollment | 57 |
Est. completion date | May 8, 2018 |
Est. primary completion date | May 8, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Male and female spine surgery patients who are at least 18 years of age 2. Surgical candidates for lateral approach lumbar spine surgery at spinal levels L2 to L5, inclusive of L4-5 3. Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the evaluation Exclusion Criteria: 1. Currently undergoing surgical treatment at any spinal level other than L2 to L5, including S1 2. Pregnant women 3. Implanted pacemaker, defibrillator, or other electronic devices 4. Involved in active litigation relating to the spine (worker's compensation claim is allowed if it is not contested) 5. Underlying neurological disease or neurological deficit that is not associated with the condition for which he/she is seeking surgical intervention (e.g., diabetic peripheral neuropathy) |
Country | Name | City | State |
---|---|---|---|
United States | Durango Orthopaedics Associates/Spine Colorado | Durango | Colorado |
United States | Pinnacle Orthopaedics & Sports Medicine Specialists | Marietta | Georgia |
Lead Sponsor | Collaborator |
---|---|
NuVasive |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reproducibility of obtaining reliable responses and response thresholds monitored over the course of surgery. | Intraoperative | ||
Secondary | Correlation of any observed changes in the response or response thresholds with surgical events. | Intraoperative | ||
Secondary | Correlation between patient characteristics and the ability to generate and reliably record responses and response thresholds. | Intraoperative | ||
Secondary | Correlation between observed changes in the response or response threshold and postoperative neural status. | 6 weeks postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00405600 -
Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone
|
N/A | |
Completed |
NCT02272140 -
Advanced XLIF Monitoring Multicenter Study
|
||
Completed |
NCT00493558 -
Spine Research With Roentgen Stereophotogrammetric Analysis
|
Phase 4 |